Search Results for 'Dabigatran'

Dabigatran published presentations and documents on DocSlides.

Update on the New Oral Anticoagulants

sherrill-nordquist
39 Slides

Eliot Williams, MD PhD. Division of Hematology &a...

A New Era in Anticoagulation Management

debby-jeon
46 Slides

Allyson Sarigianis, Pharm.D.. October 19, 2013. O...

Novel Oral Anticoagulants

natalia-silvester
88 Slides

(. N. OAC). Dan . Moellentin. , . PharmD. , BCPS,...

Management of

marina-yarberry
74 Slides

Atrial. Fibrillation. Phillip H. Lam, M.D.. Chie...

Concomitant Antiplatelet and OAC

kittie-lecroy
8 Slides

Tx. : . Real-World Practice. In the US, ~800,000 ...

Direct Oral Anticoagulants

debby-jeon
53 Slides

Eliot Williams, MD PhD. Division of Hematology &a...

Oral anticoagulants in the 21

natalia-silvester
50 Slides

st. century: A practical guide to using newer A...

An Update on Reversal Agents for NOACs: Where Are

briana-ranney
17 Slides

We Now?. Moderator. Christian T. Ruff, MD, MPH. A...

New Oral Anticoagulant

mitsue-stanley
80 Slides

R2 Patcharee Seesongsom. R2 . Sirada. . Phoja...

The Novel Oral Anticoagulants

tatyana-admore
47 Slides

Fawaz Altuwaijri. ACEM trainee. Introduction. Cha...

Safety and Efficacy of Uninterrupted Anticoagulation with

olivia-moreira
28 Slides

Dabigatran . Etexilate versus Warfarin in Patient...

Stroke, Bleeding, and

lois-ondreau
7 Slides

Mortality Risks . in . Elderly Medicare Beneficia...

ANTICOAGULATION Blake Wachter

olivia-moreira
0 Slides

, MD, PhD . Monday Morning Conference. Oct 4, 201...

The direct oral anticoagulants (DOACs)

faustina-dinatale
0 Slides

and major trauma. Dr. Tina . Biss. Consultant . ...

Dabigatran in myocardial injury after noncardiac

lois-ondreau
0 Slides

surgery. Dr. PJ Devereaux on behalf of . MANAGE I...

Journal Club Jim Hoehns,

cheryl-pisano
0 Slides

Pharm.D. .. Edoxaban. Oral factor . Xa. inhibito...

POWER IN NUMBERS: REVISITING EFFICACY & SAFETY OF

phoebe-click
0 Slides

NOACS IN AF. Where Do We Stand With NOACs in AF ...

A New Era in Anticoagulation Management

alexa-scheidler
0 Slides

Allyson Sarigianis, Pharm.D.. October 19, 2013. O...

New Oral Anticoagulants: A Review

phoebe-click
0 Slides

Babak Moini, MD. Veterans Affairs Hospital. Noon ...

Pharmacology of Anticoagulants

conchita-marotz
0 Slides

Nathan Culver, . PharmD. , BCPS. anticoagulant Me...

NOACs vs. warfarin: Pros and Cons for Patients and Providers to Consider

debby-jeon
0 Slides

Advantages of NOACs. No INR monitoring required. ...

Safe and Effective Use of Novel Oral Anticoagulants for Atrial Fibrillation: What You Need to Know

dsuser1
64 Slides

Christopher Granger, . MD. Sean Pokorney, MD. . D...

OHDSI estimation-methods papers in progress

impristic
32 Slides

Martijn Schuemie, PhD. Janssen Research and Develo...

Nonvalvular Atrial Fibrillation Anticoagulation Colour Comparison Ch

daniella
2 Slides

www.RxFiles.ca June 2021 Drug / BRAND Vitamin K ...

wvwvyzwvxv

eddey
8 Slides

coronary intervention PCI1920 As new antithromboti...

John Hanley

eve
55 Slides

Consultant HaematologistNewcastle Hospitals NHS Tr...

The thick and thin of it: Reviewing Anticoagulant Options

oneill
26 Slides

Lanae Fox, . PharmD. , BCPS. I have no financial d...

New (Direct)Oral anti-coagulants in the treatment of VTE

ariel
50 Slides

Dr NA Smith - Haematology Dept. Heart of England...

Thromboembolic protocols

cecilia
27 Slides

& safe anticoagulant prescribing. July 2020. D...

All things thrombosis Julie Wang

GirlNextDoor
58 Slides

Thrombosis Fellow. VTE is chronic disease. Recurre...

DentalUpdateNovember 2015A New Generation of Antiplatelet and Anticoag

cecilia
9 Slides

Steven Johnston, BDS, MSc, MFDS RCS(Ed), Dental Of...

Anisah Ahmad Pharmacist

genevieve
27 Slides

01904 72(4328). Anticoagulants . Warfarin . Novel ...

Dabigatran in Asia RE-LY Asia analysis and real world evidences from Asia

adah
33 Slides

NOAC vs Warfarin Atrial Fibrillation Studies – A...